Novem reports 5.6% revenue decline amid weak demand in Europe and Americas

Novem Group reported preliminary FY2025/26 revenue of €510.9 million, down 5.6%, while adjusted EBIT fell 35% to €31.8 million amid weak customer demand and macro headwinds. Full-year free cash flow rose nearly 70% to €48.1 million, and order intake exceeded €60 million, including new business in China. Management said protectionism, tariffs, weak call-offs, and FX pressure continue to weigh on the outlook, partly offset by an improved cost structure after the Germany severance program.

Analysis

The important read-through is not the headline revenue miss, but the mix shift: low-demand series revenue is being partially masked by tooling phasing and working-capital discipline. That usually means reported cash generation can look healthy for 1-2 quarters even while the underlying order book is softening, but it also tends to be a lagging signal for margin normalization once project timing fades. In other words, this is a quality-of-demand problem, not just a cyclical dip, and the margin compression suggests pricing power is still deteriorating faster than management can cut costs.

The order intake in China is the only real offset, and it matters because it hints at a potential geographic rebalancing away from Europe/Americas weakness. The second-order effect is that domestic Chinese suppliers with local content advantage could gain share faster than European export-oriented peers if tariff friction persists. For Western auto suppliers, this environment likely extends the dispersion trade: companies with higher exposure to premium OEM programs and stronger China localization should outperform those tied to weaker mass-market call-offs and punitive FX translation.

The severance program completion is a near-term earnings catalyst, but it is mostly a bridge, not a cure. Cost saves should help margins over the next 2-3 quarters, yet if customer call-offs remain weak, lower fixed costs may simply slow the bleed rather than re-rate the business. The key risk is that protectionism and tariff uncertainty keep OEM planning horizons short, which suppresses tooling conversion and delays the recovery in series revenue well into next year.

Consensus may be underestimating how much cash flow can temporarily decouple from earnings in a downcycle. That makes the stock look optically cheap if one screens on FCF yield, but the sustainability of that cash generation is fragile if receivables normalize or inventory pullbacks reverse. I would treat this as a candidate for relative-value shorting versus higher-quality auto suppliers, not as a standalone bottom-fishing setup.

Key Decisions for Investors

• Short NVM or buy put spreads on NVM into any post-print strength; use a 1-3 month horizon and target a re-rating lower as the FCF/EBIT gap closes. Risk/reward favors downside because cash flow is likely to be transient while earnings momentum remains negative.
• Pair trade: long a higher-quality auto supplier with stronger China localization and pricing power vs short a Europe-heavy supplier basket over the next 2-4 quarters. The thesis is dispersion from demand weakness and tariff noise, not broad sector beta.
• For investors seeking exposure, wait for evidence of sustained series call-off stabilization before buying any auto supplier tied to European OEMs; confirmation should come from 2 consecutive quarters of improving EBIT margin, not just order intake. Early entry here has poor asymmetry.
• If trading the sector, overweight names with net cash and lower fixed-cost sensitivity, because the next leg of the cycle likely rewards balance-sheet resilience more than headline revenue growth. Use this report as a warning against cyclically levered recovery trades.
• Monitor China-linked tooling wins as the first real catalyst for a turn; if those orders convert into repeat series business, reassess within 6-9 months. Until then, the best risk/reward remains defensive or short relative value.